4.3 Article

Treatable traits in acute exacerbations of chronic airway diseases

Journal

CHRONIC RESPIRATORY DISEASE
Volume 16, Issue -, Pages -

Publisher

SAGE PUBLICATIONS LTD
DOI: 10.1177/1479973119867954

Keywords

Acute exacerbations; chronic airway disease; asthma; COPD; bronchiectasis; treatable traits

Funding

  1. GlaxoSmithKline
  2. AstraZeneca
  3. Menarini
  4. Boehringer Ingelheim
  5. Novartis
  6. Lung Foundation Australia/Boehringer-Ingelheim COPD Research Fellowship (2017-18)

Ask authors/readers for more resources

Acute exacerbations of chronic airway disease are common occurrences that cause a major burden of illness. Acute exacerbations are associated with impaired health status, increased lung function decline, hospitalization and increased risk of death. Exacerbation avoidance is a major priority. Despite this goal, exacerbations continue to occur and the need for effective models of care that optimize patient outcomes are urgently needed. 'Treatable Traits' is an approach to personalized medicine that has been proposed for the management of airway diseases. The treatable traits approach allows for the recognition of clinically important, identifiable and treatable disease characteristics, followed by targeted and individualized treatment interventions to address each trait. We review the literature relating to treatable traits in airway diseases; in particular, those traits that can predict exacerbations and approaches to management that aim to prevent exacerbations by using a treatable traits model of care. We propose this approach as a potentially useful model of care to both prevent and manage acute exacerbations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available